[Treatment of hepatocellular carcinoma].
Hepatocellular carcinoma is one of the most common cancers worldwide. The incidence of this disease is also increasing in the Western world. Typically, HCC is diagnosed when patients have already reached an advanced stage of the disease and the prognosis is poor. Potentially curative treatment options include surgical resection or liver transplantation and can be offered to patients with adequate liver function and tumour stage. Other non-surgical treatment options such as radiofrequency ablation, cryoablation, ethanol or acetic acid injection, transarteriel chemoembolisation radiation therapy and systemic chemotherapy can be offered either alone or in combination to selected groups of patients. These treatments can improve (tumour-free) survival and in a few cases even cure the patient.
Greten
T F
TF
Abteilung Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover. greten.tim@mh-hannover.de
Blum
H E
HE
Manns
M P
MP
Geissler
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011878:Radiotherapy / Q000379:methods*; D016896:Treatment Outcome
D000970:Antineoplastic Agents